William Edward McConville
Directeur/Membre du Conseil chez Voyager Pharmaceutical Corp.
Profil
William Edward McConville is currently a Director at Voyager Pharmaceutical Corp.
and a Member at Order of Friars Minor of The Province of The Most Holy Name.
He previously worked as a Director at Auto Search Cars, Inc. in 2010, a Director at Curaxis Pharmaceutical Corp., and an Independent Director at Curaxis Pharmaceutical Corp.
from 2006 to 2011.
He was also a Professor at Siena College from 1989 to 2001.
McConville holds a doctorate degree from Vanderbilt University and an undergraduate degree from The Catholic University of America.
Postes actifs de William Edward McConville
| Sociétés | Poste | Début |
|---|---|---|
Voyager Pharmaceutical Corp.
 Voyager Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Voyager Pharmaceutical Corp. develops and manufactures drugs for age-related diseases. The company was co-founded by David J. Corcoran and Patrick S. Smith, in February, 2001 and is headquartered in Raleigh, NC. | Directeur/Membre du Conseil | - |
| Order of Friars Minor of The Province of The Most Holy Name | Corporate Officer/Principal | 17/09/2010 |
Anciens postes connus de William Edward McConville
| Sociétés | Poste | Fin |
|---|---|---|
| CURAXIS PHARMACEUTICAL CORP | Directeur/Membre du Conseil | 24/06/2011 |
Auto Search Cars, Inc.
 Auto Search Cars, Inc. Wholesale DistributorsDistribution Services Auto Search Cars, Inc. engaged in the development of a web-based e-commerce site designed to be a price leader in the online vehicle sales and service market. Inclusive in business plan is to develop its website as a platform to provide information, not just for the sale of vehicles but also for information such as vehicle financing and warranties. The company has created a platform that is local, regional and national in nature. By providing such a platform, the company can bring vehicle sellers and other industry participants, such as vendors of automotive services and advertisers, together with consumers actively engaged in a search for a vehicle or vehicle-related products. The company was founded in 2008 and is headquartered in Ridgefield, CT | Directeur/Membre du Conseil | 03/09/2010 |
| Siena College | Corporate Officer/Principal | 01/06/2001 |
Curaxis Pharmaceutical Corp. /Old/
 Curaxis Pharmaceutical Corp. /Old/ Drugstore ChainsRetail Trade Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Curaxis' initial focus is Alzheimer's Disease (or AD). The lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer's Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease. Curaxis Pharmaceutical is moving to guide their patented treatment through the necessary clinical trials in order to make it available for patients as quickly as possible. Management believes this product represents a major new development in the battle against Alzheimer's disease. Currently, no medications or treatments halt or materially slow the progression of this disease. The company's research results provide a very strong scientific explanation for the age-related onset of the disease, as well as its progressive nature. Curaxis' strategy is to initiate enrollment and dose the first patient in a Phase 2 clinical trial in women with mild to moderate Alzheimer's disease in 2010. This major step for the Company will signify the next stage in the development of Curaxis Pharmaceutical and a major milestone towards commercialization of Curaxis' treatment for Alzheimer's disease. | Directeur/Membre du Conseil | - |
Formation de William Edward McConville
| Vanderbilt University | Doctorate Degree |
| The Catholic University of America | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Voyager Pharmaceutical Corp.
Voyager Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Voyager Pharmaceutical Corp. develops and manufactures drugs for age-related diseases. The company was co-founded by David J. Corcoran and Patrick S. Smith, in February, 2001 and is headquartered in Raleigh, NC. | Health Technology |
Auto Search Cars, Inc.
Auto Search Cars, Inc. Wholesale DistributorsDistribution Services Auto Search Cars, Inc. engaged in the development of a web-based e-commerce site designed to be a price leader in the online vehicle sales and service market. Inclusive in business plan is to develop its website as a platform to provide information, not just for the sale of vehicles but also for information such as vehicle financing and warranties. The company has created a platform that is local, regional and national in nature. By providing such a platform, the company can bring vehicle sellers and other industry participants, such as vendors of automotive services and advertisers, together with consumers actively engaged in a search for a vehicle or vehicle-related products. The company was founded in 2008 and is headquartered in Ridgefield, CT | Distribution Services |
| Order of Friars Minor of The Province of The Most Holy Name | |
Curaxis Pharmaceutical Corp. /Old/
Curaxis Pharmaceutical Corp. /Old/ Drugstore ChainsRetail Trade Curaxis Pharmaceutical Corporation is a specialty pharmaceutical company dedicated to finding cures for major age-related diseases. Curaxis' initial focus is Alzheimer's Disease (or AD). The lead product is a patented treatment that has shown the potential for treating and halting the progression of this devastating disease. Today, over 5,300,000 Americans suffer with Alzheimer's Disease. It is estimated that more than $100 billion is spent annually in the United States to treat and care for those with this ailment. Sadly, these numbers are growing every day as the situation for many patients and their families grows desperate, despite the millions of dollars spent annually to find the answer to effectively treating this disease. Curaxis Pharmaceutical is moving to guide their patented treatment through the necessary clinical trials in order to make it available for patients as quickly as possible. Management believes this product represents a major new development in the battle against Alzheimer's disease. Currently, no medications or treatments halt or materially slow the progression of this disease. The company's research results provide a very strong scientific explanation for the age-related onset of the disease, as well as its progressive nature. Curaxis' strategy is to initiate enrollment and dose the first patient in a Phase 2 clinical trial in women with mild to moderate Alzheimer's disease in 2010. This major step for the Company will signify the next stage in the development of Curaxis Pharmaceutical and a major milestone towards commercialization of Curaxis' treatment for Alzheimer's disease. | Retail Trade |
Curaxis Pharmaceutical Corp.
 Curaxis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Curaxis Pharmaceutical Corp. is a specialty pharmaceutical company with a hormone drug product for the treatment of Alzheimer's disease and multiple cancers. The company was founded by Patrick S. Smith and David J. Corcoran on February 27, 2001 and is headquartered in Raleigh, NC. | Health Technology |